Trial reportGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2026
The whole-course of supervised home-based multi-modal prehabilitation to improve clinical outcome in patients undergoing neoadjuvant chemotherapy prior to gastrectomy: a single-center randomized controlled trial.
Trial report in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06521541 (Whole Course Multi-model Prehabilitation to Improve Clinical Outcome in Patients Undergoing Neoadjuvant Treatment Prior to Gastrectomy), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Whole Course Multi-model Prehabilitation to Improve Clinical Outcome in Patients Undergoing Neoadjuvant Treatment Prior to Gastrectomy : A Single Center Randomized Control Trial
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
Abstract
backgroundAlthough neoadjuvant chemotherapy offers survival benefits to advanced gastric cancer patients, the severe chemotherapy-related toxic side effects and the decline in physical fitness that accompany it increase the difficulty of perioperative management and may result in adverse clinical outcomes for patients undergoing surgery.
methodsAn open-label, Phase II, single-center randomized clinical trial was conducted in the Affiliated Hospital of Qingdao University. Patients with advanced gastric cancer who were planned to undergo gastrectomy after neoadjuvant chemotherapy were randomly assigned (1:1) to the study group (multi-modal prehabilitation) or the control group. The multimodal prehabilitation program, comprising exercise, nutritional support, and psychological intervention, was implemented over a duration of 10–16 weeks. The primary endpoint was the functional fitness between neoadjuvant chemotherapy and preoperative time point. The secondary endpoints were nutritional status, inflammatory factor levels, anxiety and depression condition, quality of life, the adherence to neoadjuvant chemotherapy, postoperative recovery, and 30-day morbidity.
resultsBetween July 2024 and January 2025, 85 participants were included in the intention-to-treat (ITT) population (43 in the study group and 42 in the control group). Compared with the control group, prehabilitation had alleviated the attenuation of cardiopulmonary fitness during neoadjuvant chemotherapy (17.3 ± 21.8 m vs. − 25.8 ± 34.9 m, P < 0.001) and improved the fitness prior to surgery (29.4 ± 26.0 m vs. − 17.9 ± 33.6 m, P < 0.001). Prehabilitation resulted in higher adherence to neoadjuvant chemotherapy, better nutritional status, and superior quality of life. Patients in the study group exhibited a significantly lower incidence of postoperative pneumonia (absolute risk difference [ARD] -12.0%, 95% CI − 23.5% to − 0.5%; number needed to treat [NNT] = 9), a reduced rate of Clavien-Dindo grade II complications (ARD − 16.8%, 95% CI − 31.8% to − 1.9%; NNT = 6), as well as faster postoperative functional recovery and a shorter length of hospital stay, all of which indicated the clinical value of prehabilitation intervention.
conclusionsThe whole course of supervised, home-based multi-modal prehabilitation improves functional capacity prior to gastrectomy, which attenuates the adverse reaction of neoadjuvant chemotherapy. Improved physical, psychological, and nutritional status preoperatively may translate to better postoperative outcomes.
trial registrationNCT06521541 ( http://www.clinicaltrials.gov ).
Indexed as
Identifiers
41870736What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.